arrow
A

Atanas Kamburov

Bayer AG
H指数:34
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity

通过Visium、GeoMx DSP和Chromium对存档肿瘤进行转录组分析,揭示了患者异质性。

2025-05-120
OA
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling
2024-07-014
PRE
Novel YAP1/TAZ pathway inhibitors identified through phenotypic screening with potent anti-tumor activity via blockade of GGTase-I and Rho-GTPase signaling
2024-03-220
PRE
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion

流式Hodgkin reed-sternberg细胞的基因组分析揭示了免疫逃避的互补机制

2019-12-09114
OA
ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer
2019-02-01113
OAAI
Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance

新型单羧酸转运蛋白1抑制剂BAY-8002和相关耐药标志物的临床前疗效

2018-11-0284
OAAI
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (vol 24, pg 679, 2018)

弥漫性大b细胞淋巴瘤的分子亚型与不同的致病机制和结果相关 (第24卷,679页,2018)

2018-06-2837
OAAI
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (vol 24, pg 679, 2018)

弥漫性大b细胞淋巴瘤的分子亚型与不同的致病机制和结果相关 (第24卷,679页,2018)

2018-06-2813
OAAI
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

弥漫性大b细胞淋巴瘤的分子亚型与不同的致病机制和结果相关

2018-04-301.3K
OAAI
NetSig: network-based discovery from cancer genomes
2017-12-0482
OAAI
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
2017-08-21405
OA